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Abstract
Although infection with any of the three types of Mansonella species that affect humans is often 
asymptomatic, a large portion of the world’s population is at risk of this vectorborne filarial nematode infection.  
No previous global review of the epidemiology of mansonelliasis has been conducted.  A systematic review of 
the literature was conducted.  Original research articles that provided population-based mansonelliasis 
prevalence rates were identified by searching the PubMed database using pre-defined eligibility criteria.  Data 
from each of the forty-six included studies were extracted and compared.  Mansonelliasis is a common infection 
in some parts of west and central Africa and Latin America, with significant variation in prevalence rates over 
small geographic spaces.  The risk of infection increases with age and may be higher in males than females.  
Despite many similarities, the three agents that cause mansonelliasis have distinct biological, clinical, and 
epidemiological characteristics.  Knowledge about mansonelliasis is important for making differential diagnoses, 
identifying the possible risks of co-infection with multiple filariases, and addressing the concerns of at-risk 
populations.  
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Introduction
Mansonelliasis is one of several filarial nematode infections for which humans are the definitive host.  
This puts it in the same category as several parasitic infections of importance to global public health, including 
onchocerciasis, lymphatic filariasis, dracunculiasis, and loiasis.  The three agents that cause mansonelliasis –
Mansonella perstans, M. streptocerca, and M. ozzardi – vary in features such as anatomy and periodicity, the 
vectors that transmit the agent to humans, the clinical signs and symptoms they cause, and the world regions 
where they are endemic.  While some of these major filarial infections have garnered international attention –
onchocerciasis (river blindness) (Gardon et al., 1997) and dracunculiasis (Guinea worm) (Barry, 2007; 
Cairncross et al., 2002) have been the focus of global eradication efforts – mansonelliasis has been neglected. 
This paper is the first systematic global review of the epidemiologic literature on all three forms of 
mansonelliasis.  A systematic search strategy was used to identify 46 original scientific articles of the prevalence 
of mansonelliasis.  These publications report on studies from 18 countries in Africa and Latin America.  After 
providing a brief background on the key features of each of the three types of mansonelliasis, this paper provides 
a comparison of the epidemiology of these infections, with an emphasis on at-risk populations and geographic 
regions.  Up-to-date epidemiological information is essential for making differential diagnoses, planning public 
health interventions, and advancing research in the field. 
Background on Mansonelliasis
Agent and Vector Characteristics 
Three types of Mansonella, which are filarial nematodes (roundworms), are known to infect humans: 
M. perstans (formerly Dipetalonema perstans), M. streptocerca (formerly Dipetalonema streptocerca), and M. 
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ozzardi (CDC, 2008; Garcia, 2007; Heymann, 2004).  The life cycles for all three species are similar, involving 
development in both an insect vector and a primate host.  Culicoides (biting midges) are effective vectors for all 
three species; Simulium (black flies) are a vector only for M. ozzardi (Shelley, 2001).  Both vectors require blood 
meals in order for their eggs to mature (Black et al., 2004).  When a female arthropod takes a blood meal from an 
infected host, microfilariae are ingested by the insect, penetrate the insect’s gut and go through several 
maturation stages in the thoracic muscles over 6 to 12 days before migrating to the head and proboscis, where 
they can be transferred to a primate through an insect bite (Black et al., 2004; CDC, 2008).  Humans are the only 
known vertebrate host for M. ozzardi; other primates can serve as host to M. perstans and M. streptocerca
(Garcia, 2007).  After the vector deposits filarial larvae onto the skin of the host, the larvae penetrate into the bite 
wound, mature into adult worms, and then the adult female worms produce unsheathed microfilariae that 
circulate in the blood (all three species) or diffuse into the skin (M. streptocerca only) of the primate host (Black, 
2004; CDC, 2008; Garcia, 2007).  All three species have non-periodic microfilariae that circulate in peripheral 
blood throughout the day and night (Garcia, 2007; Mommers et al., 1994; Service, 2004).  The size of the adult 
worms varies by species, and microfilariae differ in the shape of the tail and the distribution of body nuclei.  Key 
differences between these species are highlighted on Table 1.  
Clinical Characteristics 
Table 1 highlights key differences in signs and symptoms, diagnosis, and treatment between the three 
species.  Infection with any of the three is often asymptomatic.  Symptoms that do occur are related to the 
preferred location of the agent: M. perstans are typically found in body cavities, M. streptocerca in dermal and 
subcutaneous tissue, and M. ozzardi in subcutaneous tissues (Garcia, 2007; Heymann, 2004).  Symptoms of 
infection with M. perstans may include pectoral and chest pains, periodic dizziness, joint and back pain, and 
ocular symptoms (Anosike et al., 2005b; Bregani et al., 2006; Bregani et al., 2007).  Infection with M. 
streptocerca, which is found under the skin, is associated with cutaenous edema (build-up of fluid in the skin), 
thickening of the skin, formation of hypopigmented macules (flat blotches) and papules (raised bumps), and 
pruritus (itchiness) (Heymann, 2004; Fischer et al., 1997).  M. ozzardi may cause symptoms that include skin 
rashes, headaches, fever, pruritus, lymphedema (swelling of the arms or legs), and joint pain (CDC, 2008; 
Garcia, 2007).  
Diagnosis and Treatment 
Diagnosis and treatment also vary by species (Table 1).  Blood smears that look for microfilariae are the 
easiest way to diagnose M. perstans and M. ozzardi (CDC, 2008).  M. streptocerca microfilariae do not circulate 
in the blood, so it is necessary to take a skin snip (CDC, 2008).  Care must be taken to differentiate 
mansonelliasis from onchocerciasis or other filarial infections (Fischer et al., 1997).  Treatment must be specific 
to the infective agent.  M. perstans is most effectively treated with mebendazole; ivermectin is not effective 
against M. perstans, but is the drug of choice for treating M. ozzardi (Garcia, 2007; Heymann, 2004).  Both 
diethylcarbamazine (DEC) and ivermectin have been used to treat M. streptocerca infection (Garcia, 2007).
Methods
Systematic reviews of the literature minimize the selection bias that may occur in narrative reviews that 
select articles by hand rather than by using a strict set of inclusion criteria.  This methodical approach yields a 
valid and comparable set of research articles which together can reveal trends and gaps in the published research 
literature.  
A systematic review of original research articles focusing on the prevalence of mansonelliasis was 
conducted using PubMed, a database from the U.S. National Institutes of Health that searches all MEDLINE 
citations along with several other databases and older publications (Figure 1).  A search for “mansonelliasis” 
yielded 173 results.  The abstracts and/or full-texts of these articles were screened for eligibility.  Of the 173 
articles, 127 were ineligible: 30 that included only individuals with mansonelliasis and did not provide any 
population-based statistics, 26 that examined the vectors of infection rather than the human hosts, 22 that 
reported solely on laboratory techniques and diagnostic methods, 18 that evaluated treatment for mansonelliasis, 
16 that focused on a disease other than mansonelliasis and only mentioned mansonelliasis in the commentary, 
and 15 additional articles that did not report population-based prevalence rates.
All of the 46 remaining articles were located and read, and information about the study country, study 
years, sample size, age range of participants, and prevalence was recorded.  All languages were eligible for 
inclusion, and the 46 eligible articles were in English (39), Spanish (3), Portuguese (3), and French (1).
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Table 1:  Agent characteristics [CDC, 2004; Garcia, 2007; Heymann, 2004].
Agent Mansonella perstans Mansonella streptocerca Mansonella ozzardi
Adult Size 4-8 cm x 0.06 mm 2 cm x 0.01 mm 3-5 cm x 0.07-0.15 mm
Microfilarial 
Characteristics
100-200 μm x 5 μm;
blunt rounded tail; body 
nuclei extend to tip of tail
180-240 μm x 2.5-5 μm;
curved hooked “Shepherd’s 
crook” tail; body nuclei 
extend to tip of tail
170-240 μm x 3-4 μm;
long thin pointed tail; body 
nuclei do not extend to tip of 
tail 
Vector
Culicoides spp.
(biting midges)
Culicoides spp.
(biting midges) 
Culicoides spp.
(biting midges) and 
Simulium spp.  (blackflies)
Hosts
humans, gorillas, and 
monkeys
humans and monkeys humans
Signs / 
Symptoms
usually asymptomatic
often asymptomatic; may 
cause chronic pruritus 
(itchiness) and thick papules 
on skin
often asymptomatic; may 
cause malaise
Common Adult 
Locations
body cavities subcutaneous tissues subcutaneous tissues
Common 
Microfilarial 
Locations
blood skin blood
Diagnosis peripheral blood smear skin snip blood smear
Recommended 
Treatment
mebendazole
DEC (diethylcarbamazine) / 
ivermectin
ivermectin
Geographic 
Range
Africa and the Americas West and central Africa the Americas
Results
The goals of the systematic review were to identify the areas of the world where mansonelliasis has 
been studied, to identify the prevalence rate in affected communities, and to list the risk factors that have been 
identified for each species.  These findings are presented below and in Tables 2, 3, and 4.  
Mansonella perstans is found in both Africa and the Americas, but has primarily been studied in Africa 
(Table 2).  The prevalence in endemic areas varies greatly even within small geographic regions.  For example, a 
2003 study of school children in Uganda showed variation in school-level prevalence ranging from 0.4% to 
72.8% (Onapa et al., 2005), and a 2005-2006 study in Uganda found a rate of 57.7% in one community and 
76.5% in a neighboring community (Asio et al., 2009). Other studies from Uganda have found village prevalence 
rates as low as 2% (Onapa et al., 2001) and 21% (Hillier et al., 2008) and as high as 96% (Fischer et al., 1997).  
A study in Cameroon found village prevalence rates ranging from 55% to 100% (Wanji et al., 2003), while 
another study from Cameroon found a lower prevalence rate of 26.6% (Mommers et al., 1994).  A study of 
villages in Congo found village rates ranging from 22.0% to 89.5% (Noireau et al., 1989) and a study in Burkina 
Faso found village rates ranging from 3.5% to 14% (Kyelem et al., 2003).  Prevalence rates from other studies in 
West and Central Africa demonstrate a similarly wide infection rate, ranging from 3.2% to 47% in Nigeria 
(Agbolade and Akinboye, 2001; Akogun, 1992; Anosike et al., 1992, 2005b; Arene and Atu, 1986; Udonsi, 
1986, 1988; Ufomadu et al., 1991; Useh and Ejezie, 1995) and 6.0% in Sierra Leone (Gbakima and Sahr, 1996) 
to 49.1% in Gabon (Van Hoegaerden et al., 1987), 66.3% in Guinea (Vila Montlleo, 1990), and 75% in Mali 
(Keiser et al., 2003).  The only recent study from Latin America was conducted among an indigenous population 
in Venezuela and found a prevalence of 11.3% (Gómez and Guerrero, 2000).  A study from Colombia found a 
prevalence of 6% in affected communities in the 1980s (Kozek et al., 1983).  
Co-infection with M. perstans and other filarial infections appears to be common.  42.3% of 
onchocerciasis patients in a study in Togo were co-infected with M. perstans (Schulz-Key et al., 1993), 36.9% of 
participants in a study in Cameroon were infected with both M. perstans and O. volvulus (Wanji et al., 2003), 
14% of participants in a study in Gabon had both M. perstans and L. loa (Van Hoegaerden et al., 1987), 10.1% 
of persons with M. perstans infection in a study from Nigeria also had L. loa (Ufomadu et al., 1991), and 9% of 
participants in a study conducted in the Congo were infected with both M. perstans and L. loa and 7% had both 
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M. perstans and M. streptocerca (Noireau et al., 1989).  Given the concern that has been raised about filarial co-
infection with other agents, this may be an area of concern (Boussinesq et al., 2003; Gardon et al., 1997).
Search PubMed for “mansonelliasis”
n = 173
Remove studies that include only cases (n = 30)
n = 143
Remove animal/vector studies (n = 26)
n = 117
Remove laboratory/diagnostic studies (n = 22)
n = 95
Remove treatment/therapeutic studies (n = 18)
n = 77
Remove studies not focusing on mansonelliasis (n = 16)
n = 61
Remove studies that do not report prevalence (n = 15)
n = 46
Included studies (n = 47)
M. perstans (25)
M. streptocerca (3)
M. ozzardi (18)
                                                           Figure 1:  Search strategy.
Most studies that examined differences in M. perstans prevalence by sex found no difference between 
males and females (Agbolade et al., 2001; Asio et al., 2009; Boussinesq et al., 2003; Gbakima and Sahr, 1996; 
Ufomadu et al., 1991; Useh et al., 1995) although several other studies observed a higher rate in males than 
females (Anosike et al., 2005b; Mommers et al., 1994; Noireau et al., 1989; Wanji et al., 2003). Studies of the 
association between age and infection consistently found a higher rate in adults than children (Agbolade et al., 
2001; Anosike et al., 2005b; Asio et al., 2009; Gbakima and Sahr, 1996; Keiser et al., 2003; Mommers et al., 
1994; Noireau et al., 1989; Ufomadu et al., 1991; Wanji et al., 2003).
Mansonella streptocerca occurs in west and central Africa, and has been the focus of relatively few 
studies (Table 3).  As was found for M. perstans, the prevalence rate appears to vary widely within endemic 
areas.  A study in western Uganda in the mid-1990s found that the village prevalence ranged from 5% to 89% 
(Fischer et al., 1997).  A study from the 1980s conducted in the Central African Republic found a prevalence of 
13.5% (Okelo et al., 1988) and a study in Nigeria from the early 1990s found a prevalence of 0.5% (Anosike and 
Onwuliri, 1994).  Additional studies are required to establish the geographic range where this agent is endemic 
and to identify risk factors. 
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Table 2.  Epidemiological studies of M. perstans.
Country Study Year Sample Size
Age Range 
(years)
Prevalence Reference
Colombia -- 604 -- 6% Kozek, 1983
Burkina Faso 2001 3303  1 6% Kyelem, 2003
1992 466  0.5 27% Mommers, 1994
Cameroon
-- 1458  15 70% Wanji, 2003
Congo 1985-1986 2313  1 29% Noireau, 1989
Gabon 1984-1985 411 9-70 49% Van Hoegaerden, 1987
Guinea 1989 829  10 66% Vila Montlleo, 1990
Mali -- 40 18-65 75% Keiser, 2003
2003-2004 373 -- 3 % Anosike, 2005a
1996-2000 755  5 9% Anosike, 2005b
1997-1998 373 4-55 3% Agbolade, 2001
1988-1991 4183 0-70 29% Anosike, 1992
1993 840  1 15% Useh, 1995
1989 2552 -- 11% Akogun, 1992
1984-1987 940 3-80 8% Ufomadu, 1990
-- 845 -- 13% Udonsi, 1988
1983-1984 1674  1 47% Arene, 1986
Nigeria
-- 1351  1 46% Udonsi, 1986
Sierra Leone 1993 630 5-70 6 % Gbakima, 1996
Togo -- 182 -- 42% Schulz-Key, 1993
2005-2006 1566  1 65% Asio, 2009
2003-2005 2499 14-47 21% Hillier, 2008
2003 12207 5-19 61% Onapa, 2005
1998 3548 -- Onapa, 2001
1994-1995 233  14 96% Fischer, 1997a
Uganda
1991-1993 1543  14 49% Fischer, 1996
--: information not provided in article
Table 3:  Epidemiological studies of M. streptocerca.
Country Study Year Sample Size
Age Range 
(years)
Prevalence Reference
Central African 
Republic
-- 267 1-100 14% Okelo, 1988
Nigeria 1990-1992 1349 0-70 0.5% Anosike, 1994
Uganda 1994-1995 806  14 61% Fischer, 1997a
--: information not provided in article
Mansonella ozzardi infection, also known as mansonellosis, occurs only in the Americas (Table 4).  In 
the past ten years, the results of cross-sectional studies from Brazil (Cohen et al., 2008; Garrido and Campos, 
2000; Medeiros et al., 2008), Bolivia (Bartoloni et al., 1999), and Venezuela (Gómez and Guerrero, 2000) have 
been published.  Most of the studies in Brazil and Venezuela were conducted in communities located along 
rivers in the Amazon basin and focused on indigenous groups.  The prevalence rates ranged from 9.9% (Gómez  
and Guerrero, 2000) to 18.9% (Cohen et al., 2008) to 28.2 % (Garrido and Campos, 2000) to 30.2% (Medeiros et 
al., 2008).  Older studies from Brazil found prevalence rates ranging from 4% (Shelley, 1975) to 27% (Lage, 
1964).  The Bolivian study also focused primarily on an indigenous population, and found a total prevalence of 
0.7% in one town and 26% in a neighboring town of 26% (Bartoloni et al., 1999), which suggests the same 
diverse range of prevalence rates found for the other species.  Prevalence rates from studies of rural areas in 
Venezuela ranged from 11% (Beaver et al., 1976) to 22% (Le Bras et al., 1978) to 30% (Formica and Botto, 
1990) to 36% (Medrano et al., 1992) to 58% (Godoy et al., 1980).  In a study from the 1970s, about 16% 
(Raccurt et al., 1980) of inhabitants surveyed from Bayeux, Haiti, were found to be infected with Mansonella 
ozzardi.  In Colombia, prevalence rates ranged from 3% (Kozek et al., 1984) to 13% (Kozek et al., 1983) to 49% 
(Lightner et al., 1980).  These studies consistently found that risk of infection increased with age (Bartoloni et 
al., 1999; Le Bras et al., 1978; Medeiros et al., 2008; Nathan et al., 1979). Although one study from Trinidad in 
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the 1970s indicated an increased risk of infection in males (Nathan et al., 1979), more recent studies from 
Bolivia (Bartoloni et al., 1999) and Brazil (Medeiros et al., 2008) found no differences in prevalence by sex.  
Thus, aside from age no risk factors have been firmly established. 
Table 4:  Epidemiological studies of M. ozzardi.
Country Study Year Sample Size
Age Range 
(years)
Prevalence Reference
Bolivia 1997 594 0-85 26% Bartoloni, 1999
2007 129  2 30% Mederios, 2008
2006 543 -- 19% Cohen, 2008
-- 496 -- 28% Garrido, 2000
-- 386 -- 4% Shelley, 1975
Brazil
-- 262 -- 27% Lage, 1964
-- 347 8-70 49% Lightner, 1980
-- 627 -- 3% Kozek, 1984Colombia
-- 604 -- 13% Kozek, 1983
Haiti -- 1165 all 16% Raccurt, 1980
Mexico 1956 329 -- 61% Biagi, 1956
Trinidad -- 4,488  5 5% Nathan, 1979
-- 1057 -- 10% Gomez, 2000
1983-1989 423 -- 36% Medrano, 1992
-- 139 -- 58% Godoy, 1980
1977 146  6 22% Le Bras, 1978
Venezuela
-- 187 -- 10% Beaver, 1976
--: information not provided in article
Discussion
While the three agents that cause mansonelliasis share these similarities, they are distinct infections 
with unique agent, clinical, and epidemiological characteristics.  Although infection is usually asymptomatic, 
millions of people worldwide – especially those in rural areas – are at risk.  This systematic review shows that 
mansonelliasis may be a common infection in parts of Latin American and west and central Africa, with 
significant variation in prevalence rates over small geographic spaces, but the review also highlights the lack of 
current information about the prevalence of mansonelliasis in most areas likely to at risk.  Also, although the 
review indicates that the risk of infection increases with age and may be higher in males than females, there is a 
need for additional work to identify specific demographic and environmental risk factors.  Updated information 
will be important for making differential diagnoses in endemic and epidemic areas, promoting measures to 
control vectors in areas with significant burden from the disease, identifying the possible risks of co-infection 
with multiple filariases, and addressing the concerns of at-risk populations. 
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